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Abstract
Microbeam Radiation Therapy (MRT) is a preclinical form of radiosurgery dedicated to brain tumor treatment. It uses
micrometer-wide synchrotron-generated X-ray beams on the basis of spatial beam fractionation. Due to the radioresistance
of normal brain vasculature to MRT, a continuous blood supply can be maintained which would in part explain the
surprising tolerance of normal tissues to very high radiation doses (hundreds of Gy). Based on this well described normal
tissue sparing effect of microplanar beams, we developed a new irradiation geometry which allows the delivery of a high
uniform dose deposition at a given brain target whereas surrounding normal tissues are irradiated by well tolerated parallel
microbeams only. Normal rat brains were exposed to 4 focally interlaced arrays of 10 microplanar beams (52 mm wide,
spaced 200 mm on-center, 50 to 350 keV in energy range), targeted from 4 different ports, with a peak entrance dose of
200Gy each, to deliver an homogenous dose to a target volume of 7 mm
3 in the caudate nucleus. Magnetic resonance
imaging follow-up of rats showed a highly localized increase in blood vessel permeability, starting 1 week after irradiation.
Contrast agent diffusion was confined to the target volume and was still observed 1 month after irradiation, along with
histopathological changes, including damaged blood vessels. No changes in vessel permeability were detected in the
normal brain tissue surrounding the target. The interlacing radiation-induced reduction of spontaneous seizures of epileptic
rats illustrated the potential pre-clinical applications of this new irradiation geometry. Finally, Monte Carlo simulations
performed on a human-sized head phantom suggested that synchrotron photons can be used for human radiosurgical
applications. Our data show that interlaced microbeam irradiation allows a high homogeneous dose deposition in a brain
target and leads to a confined tissue necrosis while sparing surrounding tissues. The use of synchrotron-generated X-rays
enables delivery of high doses for destruction of small focal regions in human brains, with sharper dose fall-offs than those
described in any other conventional radiation therapy.
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Introduction
Dose delivery in brain radiosurgery is limited by the tolerance of
normal tissues surrounding the target. In some particular cases, the
dose gradients (from the irradiated target to surrounding sensitive
structures) achievable with high-energy photons (MeV) do not
allow curative doses to be delivered at the target without injuring
adjacent functional structures [1,2]. Brain treatment research
based on kilovoltage-photons was discontinued when Leksell
introduced the radiosurgery technique in the early 509s [3].
Nowadays, kilovoltage X-rays are considered as inefficient for
most clinical applications by radiotherapists because of their low
penetrative capability. Indeed their use is limited to treatments of
superficial diseases.
Here we show the potential applicability of low-energy photons
for irradiation of small circumscribed brain regions with sub-
millimeter precision. Microbeam Radiation Therapy (MRT) [4,5],
an innovative radiosurgical technique, takes advantage of the
particular properties of synchrotron generated X-rays (50–
350 keV) to deliver very high doses (several hundreds of Gy)
using arrays of spatially distributed quasi-parallel microplanar
beams (MBs) (25–75 mm wide and spaced 100–400 mm on-center).
The fundamental phenomenon of the large dose-volume effect at a
microscopic scale, firstly described by Zeman and Curtis in the
609s [6–8], can presently be performed only at 3
rd generation
synchrotron sources. Those can provide an adequate dose rate,
energy spectrum and a minimal beam divergence, allowing the
deposition of the steep dose gradients between MBs. The strong
PLoS ONE | www.plosone.org 1 February 2010 | Volume 5 | Issue 2 | e9028radioresistance of normal brain vasculature [9,10] to spatially
fractionated exposures to MBs may prevent the decrease in brain
perfusion and hypoxia observed after conventional radiotherapy
[11,12]. Further, by interlacing arrays of MBs and delivering them
to a target via several ports [13], normal tissues surrounding the
target will be exposed to a well tolerated, spatially fractionated
dose, whereas the radiation target will receive a high homogenous
radiation dose.
In this study, we show that it is possible to induce a focal
damage in the caudate nucleus of normal rat brains by interlacing
4 arrays of 10 MBs separated by a 45u rotation angle. The 7 mm
3
lesion and the surrounding tissues were observed up to one month
using MRI and immunohistopathology. As a proof of principle for
the relevance of the method, we used interlaced arrays of
microplanar beams (IAMB) to treat seizures in the Genetic
Absence Epilepsy Rats from Strasbourg (GAERS) [14,15]. A
complementary dosimetry study using a human-sized head
phantom highlights advantages for the potential use of synchro-
tron low-energy photons for clinical brain radiosurgery.
Methods
All operative procedures related to animal care strictly
conformed to the Guidelines of the French Government (licenses
380324 and A3818510002). Experiments were performed under
anesthesia, 5% isoflurane for induction, intraperitoneal injections
of xylazine/ketamine for irradiations (64.5/5.4 mg.kg
21) and
2.5% isoflurane for MRI follow-up were used for maintenance.
Radiation Source
IAMB irradiations were performed on the ID17 biomedical
beamline at the European Synchrotron Radiation Facility
(Grenoble, France) [16]. IAMB uses X-rays emitted tangentially
from relativistic electron bunches circulating in a storage ring. The
wiggler source (a magnetic structure of alternating poles positioned
on a straight section of the storage ring) produces a wide spectrum
of photons which extends, after filtration (Be (0.5 mm), C
(1.5 mm), Al (1.5 mm) and Cu (1.0 mm) from 50 over 350 keV
(median energy: 107 keV). The quasi-laminar beam was collimat-
ed into an array of rectangular MBs of 52 mm62 mm (width x
height) with 2 pairs of slits positioned about 42 m from the photon
source and 1 m upstream from the head of the animals. The dose
rate in air at the animal surface was approximately 16 000 Gy.s
21.
Irradiation Geometry (Right Caudate Irradiation)
The animals were fixed by the teeth in a vertical position, on a
home made Plexiglas frame and placed in front of the X-rays source
on a Kappa-type goniometer (Huber, Germany), with which the rat
can be translated and rotated. Stereotaxic coordinates of the
‘‘radiation target’’, i.e., the tissue volume in which the 4 arrays
interlaced, were measured on MRI images based on external marks
of the animal head. The irradiation geometry is depicted on Fig. 1.
The center of the target was located in the right caudate nucleus, at
the intersection of 3 planes: a) 10 mm posterior to a coronal plane
centered externally on both eyes; b) 3 mm to the right of the mid-
sagittal plane, and c) 6.8 mm below a horizontal plane on the top of
the rat’s head. Each port of irradiation was composed of 10 MBs,
52 mm wide, spaced 200 mm on-center. The first irradiation
exposure was performed after an axial 245u rotation around the
center of the target volume (position 245u). The rats were then
replaced to the initial position (position 0u)b ya4 5 u rotation and
moved down by 50 mm before the second exposure. This cycle was
repeated twice for the exposures at positions +45u and +90u,
respectively. The 50 mm z-step applied between each irradiation
Figure 1. Schematic representation of the irradiation geometry in normal rats. (A–C). Four arrays of 10 MBs (50 mm wide, 200 mm on-
center distance) were interlaced and created a 26262.2 mm
3 target region where the radiation dose is homogenous. D- GafchromicH film image of
interlaced MBs; the upper part corresponds to a centre-to-centre distance of 200 mm. The radiation target corresponds to the region where all the 4
arrays of MBs interlaced. E- Dose profiles measured on the GafchromicH film shown in (D). The red line shows the dose in the interlaced region. The
dose profile produced in the spatially fractionated irradiation and which is delivered by a single array of MBs is shown with the black line.
doi:10.1371/journal.pone.0009028.g001
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3 target volume in which all MBs were interlaced.
The in-microbeam entrance dose was fixed at 200 Gy. Uniformity
and the size of the MBs were checked with the help of GafchromicH
films. The incoming spatially non-fractionated dose was measured
using an ionization chamber and the mid-valley doses were
calculated with Monte Carlo (MC) simulations.
As a control group, we irradiated 4 rats with 4 intersecting (non-
interlaced) MBs arrays (2 mm high, 52 mm wide and spaced
200 mm center-to-center) with an angle of 45u between each array.
According to MC simulations, the resulting peak dose at the
intersection site (right caudate nucleus, 1 cm depth) was 700 Gy
for a skin entrance dose of 200 Gy delivered in each port.
Monte Carlo Simulations and Dose Calculations
The 2006 version of the MC code PENELOPE was used to
calculate the radiation dose distributions inside a rat, as well as a
human-head phantom [17]. Both phantoms were considered to be
made entirely of water. The same code has also been used in
earlier studies to characterize the doses used in MRT [18].
PENELOPE is a Monte Carlo code, with which it is possible to
simulate the coupled photon and electron transport through
arbitrary amorphous media. The most common electron and
photon interactions are accounted for as well as the production of
secondary particles with a kinetic energy above a certain creation
threshold. The paths and energy losses of the X-rays and the
secondary electrons they generate were in this work followed down
to a cutoff energy of 1 keV. For the X-ray spectrum used in MRT
(mean energy ,107 keV) the most common interaction type in
tissue-like materials is Compton scattering. The so called mixed
simulation parameters for electron scattering in PENELOPE were
set to small values (C1=C2=0.01) to make sure that the program
is running mainly in the so-called detailed simulation mode, where
all electron collisions are handled individually, no matter how
small the collision/deflection is.
In this work, the dose distribution produced by a single,
rectangular (‘‘planar’’) x-ray microbeam was simulated inside the
head phantoms which had a cylindrical shape. The X-rays were
set to start on top of the cylinder surface with a direction parallel
with the cylinder axis. The X-ray energies of the incident beam
were sampled from the spectrum measured at the ESRF. Since the
divergence of the X-ray beams produced at synchrotrons is small,
the microbeams were considered to be perfectly parallel in the
simulations and incident perpendicular to the phantom surface.
Doses were scored at different depths in the phantom, in volume
elements (voxels) with the shape of parallelepipeds [e.g. inside the
microbeam the volume element size was 1 mm (transverse
direction) 6 the microbeam height 61 mm (the element length
in the depth direction). Further away from the center of the
microbeam, in the transverse direction, the voxel size was
increased to obtain good statistics. A transversal dose profile for
a chosen depth was then prepared from the simulation output.
Using the dose profile for a single microbeam, the composite dose
distributions for the same number of microbeams as was used
experimentally was obtained by using an addition/superposition
procedure described in Siegbahn et al. [19]. Finally, the positions
of the centermost peak and valley doses in the composite dose
distribution for the microbeam array were located and the so
called PVDR (Peak-to-Valley Dose Ratio) was evaluated.
Monte Carlo simulation and dose calculations in the rat
brain. The rat head was simulated by a water cylinder of 3 cm
height and of 1.5 cm radius. A microbeam field size of 50 mm
(width) 62 mm (height) was used in the simulations. Each
microbeam array contained 10 microbeams and therefore 40
microbeams were interlacing in the irradiation target. For the
calculation of the dose distribution produced in the rat head by
IAMB, it was assumed that the distance from the entrance point
for all four microbeam arrays (at the rat head surface) to the point
of cross-firing was 1 cm. The four microbeams arrays then
produced an identical dose distribution at 1 cm depth,
independent of the angle of incidence. In that way, the resulting
dose distribution in the cross-fired volume, when using the
interlaced technique, was obtained by adding the dose profile at
1 cm depth for a single microbeam 40 times, with an incremental
shift of 50 microns for each added microbeam. For the control
group with 700 Gy (non-interlaced) target dose, the same relative
dose distribution as that calculated for a single microbeam array
was used.
Monte Carlo simulations and dose calculations in a
human-sized head phantom. The human head was simulated
by a water cylinder of 16 cm height and of 8 cm radius. In this case
the simulations were done for three different array sizes: 262m m
2,
161c m
2and 363c m
2.Thelattertwoarraysizeswerebelievedtobe
of potential interest to treat tumors in humans. The simulations and
calculations were then done in analogy to those done for the rat head.
More detailed calculations were done in the human head phantom of
the variation of the peak and valley doses with depth.
Magnetic Resonance Imaging
MRI experiments were performed at 7T (Bruker Avance III
system) using a quadrature volume coil. After anesthesia, a
catheter filled with heparinized saline was inserted into the dorsal
tail vein of the animal. Three to eight rat brains were imaged at
different delays after exposure i.e. 1, 4, 7, 15 and 30 days.
Radiation-induced anatomical changes were assessed on T2-
weighted images (RARE sequence. TR: 5 s, effective TE: 33 ms,
FOV: 363c m
2, matrix: 64664, 0.5 mm-thick). The apparent
diffusion coefficient (ADC) of water was mapped from day 4 to day
30 after irradiation using a diffusion tensor MR sequence (DTI-
EPI, TR: 2.5 s, TE: 30 ms, FOV: 363c m
2, matrix: 64664,
1 mm-thick, 3 reference images and 6 directions with
b=1000 s.mm
22). Brain vessel permeability was then character-
ized using a T1-weighted MR sequence (RARE sequence. TR:
950 ms, effective TE: 7.7 ms, FOV: 363c m
2, matrix: 64664,
0.5 mm-thick) acquired 5 min after an intravenous injection of
Gd-DOTA (200 mmol.kg
21). Two regions of interest were defined:
the radiation target in right caudate and the contralateral left
caudate nucleus. A two way ANOVA test (Bonferroni posttest)
was used to compare data across groups (*: p,0.05, **: p,0.01,
***: p,0.001).
Immuno/Histological Analyses
One, 7, 14, and 30 days after IAMB, four rats were randomly
chosen and killed by Dolethal overdose. Twenty mm thin coronal
brain sections were cut at 220uC on a cryostat (Microm HM560,
France) and stained with hematoxylin/eosin. For immunohistol-
ogy, sections were fixed with PFA 4% for 15 min and blocked with
donkey normal serum (DNS, Interchim) diluted in phosphate-
buffered saline (PBS) 1X for one hour (PBS/DNS 5%). For
neuronal staining, the sections were pretreated with alcohol 50%
in PBS for 1 h at room temperature, then incubated with the
primary antibody (NeuN, 1/1000, Chemicon) in PBS-Triton 0.3%
for 48 h.Other immunolabelings were performed as previously
described [20]. Primary antibodies used included: Glial fibrillary
acidic protein (1/2000, anti-GFAP, Z0334 DakoCytomation);
Collagen IV (1/800, F-5202 VF83, UNLD); ED1: (1/2000,
AbC117-6714, AbCys); pH2AX (1/500, 05636, Upstate); Ki67
(1/200, Clone S6, Lab Vision Corporation, Fremont) diluted in
PBS/NDS 1%. Sections were washed 4 times with PBS, then
Synchrotron X-Ray Radiosurgery
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donkey F(ab’)2 (1/200, # A31571, A11056, A11055, A10040,
A21206, Invitrogen) for 2 h at room temperature and nuclei were
counterstained by DAPI (1 mg.ml
21 in mounting medium). The
sections were examined with a Nikon Eclipse E600 microscope
equipped for epifluorescence with x10 and 20 X objectives.
Bilateral IAMB Irradiations of Somatosensory Cortex in
the GAERS Rat
As a proof of concept, bilateral IAMB irradiation of the
somatosensory cortex, shown to initiate spontaneous epileptic
seizures, were performed in the GAERS [14,15]. Rats were
irradiated with a 200 Gy entrance dose using two different MB
arrays which generated two contiguous radiation targets (4.1 and
2.7 mm long, 1.5 mm high). Ten days after irradiation, anesthe-
tized GAERS were placed into a stereotaxic frame. Three stainless
steel wire bipolar electrodes were implanted in the S1 somatosen-
sory cortex (anteroposterior (AP), 0 mm; medio- lateral (ML),
4.6 mm; dorsoventral (DV), 23.0 mm), in the motor cortex (AP,
3.2 mm; ML, 2.0 mm; DV, 22.0 mm) and in the ventral
posteromedian nucleus of the thalamus (AP, 2.5 mm; ML
2.7 mm; DV 25.4 mm) with the bregma as the reference. A
reference electrode was placed over the cerebellum. All electrodes
connected to a female connector. Six electroencephalograms
(EEG) were recorded (System Plus, Micromed France SAS) on
freely moving rats between D18 and D55 after exposure. We
report the cumulated duration (min) of the 7–9 Hz spike waves
discharges monitored per hour in control (unirradiated) and
irradiated groups.
Results
Post-Irradiation Animal Behavior
All rats irradiated in the right caudate nucleus survived the
observation period of 1 month without any sign of neurological
disorder; the evolution of their body weight was recorded as
normal (data not shown). A slight hair loss was observed at the
entrance site of each of the 4 different arrays of MBs between 14
days and 1 month after irradiation.
Normal Rat Dosimetry
The irradiation geometry and experimental dosimetry for rats
irradiated in the right caudate nucleus are shown in Fig. 1. As
shown on the gafchromicH film in Fig. 1D, the 4 arrays of 50 mm
wide MBs interlaced correctly in the radiation target. The dose
profile (Fig. 1E) read by optical density on the gafchromicH film
after exposure revealed that the quasi-homogenous radiation dose
measured in the interlaced region was higher than the one
measured in the MBs path. Monte Carlo simulations showed that
the dose in the radiation target was 200 Gy, while the in-MBs dose
at 1 cm depth would be of 175 Gy. The corresponding valley dose
in the surrounding tissues was 3.1 Gy (PVDR,56).
MRI Follow-Up of the Radiation-Induced Cerebral Lesion
The evolution of the brain lesions in the rats with IAMB
irradiation of the right caudate nucleus was imaged by MRI one,
4, 7, 15 and 30 days after irradiation (Fig. 2). No changes were
observed between 24 h and 4 days after irradiation. There was no
significant difference in T1w and T2w values between the
irradiated target and the contralateral hemisphere (Fig. 2G–H).
At D7 after exposure, 3/7 rats exhibited Gd-DOTA extravasation
in the radiation target (Fig. 2B). T1w values became significantly
higher in the radiation target at D15 after IAMB irradiation, when
8/8 rats exhibited Gd-DOTA diffusion in the brain parenchyma
(Fig. 2C). However, there was no time-matched modification of
ADC and T2w values (Fig. 2I). At D30 after interlaced MRT, 8/8
rats showed a highly localized extravasation of Gd-DOTA and
T1w values were higher than the T1w at D15 (Fig. 2D–E–G).
These changes were correlated with a significant increase in ADC
and T2w values (Fig. 2H–I). T1w and T2w hypersignals were
detectable on 4 to 5 MR slices (Fig. 2F), i.e., on a vertical distance
of ,2.25 mm. A three-dimensional representation of the radia-
tion-induced lesion is shown in Fig. 2E.
The rats in the control groups (identical, but non-interlacing
arrays) received an 700 Gy peak dose in the MB paths in the tissue
volume delimited by the intersection of the 4 arrays. The
calculated mid-valley dose was 12.5 Gy. The rat brains were
imaged at D30, e.g. when the IAMB irradiation induced the most
important brain changes in rats as detected by MRI. No
extravasation of Gd-DOTA or modification in T1w and T2w
values were found in those control animals exposed to non-
interlacing arrays (Fig. 3).
(Immuno)histological Analysis of the Cerebral Lesion
Evolution
The paths of MBs and signs of radiation induced-DNA damage
were evident in cH2AX immuno-labeled sections; ionizing
radiation induces DNA double strand breaks which were linearly
correlated with the number of gamma-H2AX foci within cell
nuclei [21]. Figure 4A–B shows the irradiation pattern, observed
24 h after exposure, in the left hemisphere, opposite to the
radiation target, i.e., approximately 50 mm-wide tracks spaced
about 200 mm on-center. Conversely, the right caudate nucleus,
exposed to the 4 interlaced arrays, exhibited a quasi-uniform
pH2AX labeling (Fig. 4C–D). One day after irradiation, cellular
details and the paths of the MBs were not identifiable on sections
stained with hematoxlin and eosin (Fig. 5A–B). The number of
gamma-H2AX foci in both locations decreased with time after
irradiation. Few of them remained detectable at D7 (Fig. 5E–F)
and no cell nucleus was labeled from D15 to D30 after exposure.
However, on D14, small (up to 1 mm diameter) perivascular tissue
zones in the left caudate nucleus displayed loss of cohesion,
presence of few nuclear fragments, hypocellularity, eosinophilia,
and minute focal hemorrhage on sections stained with hematox-
ylin and eosin. Few polymorphonuclear granulocytes and
mononuclear cells were present in such areas. On D30, the left
caudate nucleus appeared larger than the right one, displaying
areas up to 1.5 mm in diameter with lack of normal tissue
cohesion, hypocellularity, diminished eosinophilia, many intersti-
tial microvacuoles and prominent perivascular Virchow-Robin
spaces (Fig. 5M–N).
Immunohistochemistry for ED1 showed a time-related increase
of macrophages/monocytes number in the radiation target. The
maximal number of macrophages/monocytes in the interlaced
region was detected at D30 after exposure. On the contrary, the
spatially fractionated, non-interlaced irradiation mode did not
induce such cellular responses in the left, contralateral hemisphere
(Fig. 5C–D, O–P). An analogous labeling pattern was observed for
the Ki67 antibody: immunoreactive cells were only detected in the
radiation target; they reached a maximum 1 month after
irradiation (Fig. 5E–F, Q–R). An important proportion of Ki67
positive elements were endothelial cells (data not shown). Type IV
collagen labeling revealed an important rarefaction of brain vessels
in the radiation target. This decrease was prominent one month
after irradiation. Simultaneously, the diameter of the remaining
brain vessels increased markedly. These modifications of the
vascular network morphology were confined to the radiation
target (Fig. 5 H–T). No similar changes were observed in the
Synchrotron X-Ray Radiosurgery
PLoS ONE | www.plosone.org 4 February 2010 | Volume 5 | Issue 2 | e9028Figure 2. Temporal MRI follow up of the radiation target. A-D- MR characterization (T1-weighted images 5 min after Gd-DOTA injection) of the
evolution of the radio-induced lesion between D1 and D30 after exposure. E-Three-dimensional reconstruction of the irradiated target (blue) based
on Gd-DOTA extravasation on T1-weighted images at D30 after exposure. F-T2-weighted MR images acquired irradiation and reflecting brain edema
in the radiation target indicated by a white arrow. G-I Evolution of the T1,T 2 (arbitrary values) and ADC values measured at different delays after
irradiation in the radiation target (red lines) and in the contralateral hemisphere (black lines). ***: significantly different from time matched control
(p,0.001).
doi:10.1371/journal.pone.0009028.g002
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Microplanar irradiation induced astrocyte activation (intensifica-
tion of the GFAP labeling) in both hemispheres but was only
visualized in the radiation target at D30 (Fig. 5 I–J, U–V). Finally,
neuron nucleus size and shape became inhomogeneous, some
nuclear fragments were detected and some neurons presented
vesiculations at the nucleus/cytoplasm interface, 30 days after
exposure in the radiation target, whereas no change was observed
on the contralateral side (Fig. 5 K–L W–X).
Bilateral IAMB Irradiations of Somatosensory Cortex in
the GAERS Rat
To illustrate a possible practical application of IAMB
irradiation, we used the Genetic Absence Epilepsy Rats from
Strasbourg (GAERS) which are characterized by spontaneous
bilateral and synchronous 7–9 Hz spike-wave discharges (SWDs)
on the cortical EEG concomitant with behavioral arrests. Recent
data showed that SWDs would be initiated in the somatosensory
(S1) cortex coding for head and whiskers before their diffusion to
the rest of the cortex and the ventro-basal thalamus [14,15]. The
results obtained by EEG monitoring showed that a bilateral
irradiation (Fig. 6A and B) with an entrance dose of 200 Gy of the
S1 cortex in GAERS reduced (,50%) the occurrence and
duration of SWDs for 2 months (Fig. 6C).
Human-Sized Head Phantom Dosimetry
Table 1 gives a summary of the required peak entrance dose for
3 different target volumes, considering an interlacing geometry
with 50 mm FWHM from either 4 ports (200 c-t-c spacing) or 8
ports (400 c-t-c spacing). The dose to be delivered to the target
(262m m
2,1 61 and 363c m
2 target) was chosen to be 100 Gy
and the main factors responsible for a different dose distribution in
depth (7.5 cm) are described. The Interlacement Enhancement
Factor (Int. EF) corresponds to the fractional increase in radiation
dose delivered to the target by 4 or 8 interlacing arrays of MBs
versus the in-MB dose delivered by a single array of MBs. The
entrance peak and valley doses for the different MB array
configurations are shown, including the attenuation of the peak
dose at 7.5 cm depth. The contribution from scattered photons to
the peak dose becomes noticeable at larger depths and for larger
MB arrays with smaller inter-beam spacings. These simulations
show that whatever the irradiation field considered, peak and
valley entrance doses required to deliver an homogeneous
irradiation dose of 100 Gy at 7.5 cm depth are less than 300
and 10 Gy respectively.
In Fig. 7A the PVDR’s for the different MB configurations are
plotted and show clear decrease for increasing MB array size as
well as 200 mm versus 400 mm MB spacing. In Fig. 7B, the
variation of the MB peak and valley doses with depth are shown
for a 161c m
2 array of 50 mm wide MBs. The maximum peak
dose is barely affected by the change in MB separation (from
400 mm to 200 mm). The valley dose on the other hand drastically
increases by a factor of approximately three when the interbeam
spacing is halved. In Fig. 7C the dose distribution from one port of
a microbeam array is shown compared with the dose distribution
in the interlaced region at identical depths. The absolute dose is
Figure 3. Effects of interlaced vs. non-interlaced microbeam irradiations on normal brains. MR transverse and coronal T1w images (5 min
after Gd-DOTA i.v. injection) acquired 30 days after interlaced (A) and non interlaced MRT (B). The extravasation of the constrast agent is only
detectable after interlaced MRT, the 700 Gy peak dose, resulting from superimposed but non interlaced MRT does not induce Gd-DOTA extravasation
in the brain parenchyma.
doi:10.1371/journal.pone.0009028.g003
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from electrons and X-rays scattered laterally from other
microbeams. In fig. 7D, the dose produced by a MB array and
the dose distribution in the interlaced region produced by 4 MB
arrays is compared with the dose profile obtained with the Leksell
Gamma Knife (LGK) PerfexionH. This dose profile has been
calculated for a single exposure targeted to the middle of a water
head phantom of diameter 16 cm. The profile has been extracted
in the anterior-posterior direction of the head (the Y-direction
according to LGK coordinates). The 90-10% lateral dose falloff
from the non-interlaced and interlaced MB array edge occurs
within a distance of 50 mm, compared with LGK where the
penumbra extends over a distance of about 9 mm.
Discussion
The results of the present study show that IAMB irradiation
induced highly localized brain damage in the rat which was
confined to the radiation target while the unidirectionally
irradiated contralateral brain was spared. Gd-DOTA extravasa-
tion and increased ADC and T2W shown by MRI suggested an
increase in blood brain barrier (BBB) permeability. This was
associated with changes in brain vessel morphology, numerical
increase in proliferating cells, monocytes/macrophages and
astrocyte activation, as evidenced by immunohistochemical
labeling. The effectiveness of IAMB was validated by the
suppression of spontaneous seizures obtained after irradiation of
the cortical focus in GAERS rats. Finally, Monte Carlo
simulations for this technique performed on a human head
phantom suggested the feasibility of this technique in clinical
conditions. Altogether, the results obtained in this work highlight-
ed the potential use of synchrotron light for therapeutic
irradiations for human brain radiosurgery.
Brain Tissue Tolerance to Interlaced Microbeams
The IAMB irradiation concept was first introduced in 2005 by
Bra ¨uer et al. [13]. It was based on the use of 2 arrays of 25 mm-
wide microplanar beams (200 mm on-center distance) which
generated an interlaced region where the distance between
2 MBs was 100 mm. Thus, the valley dose (dose generated by
Compton effect/secondary electrons and deposited between two
MBs) could be increased by a factor of 3 as compared to the
unidirectionally irradiated regions. A uniform dose deposition
mode has been recently used by interlacing two arrays (90u)o f
parallel minibeams (680 mm wide) [22]. At a 120Gy entrance dose,
a ‘‘nearly perfect’’ lesion of 40 mm
3 was observed whereas massive
edema, which extended in the contralateral hemisphere, and
important brain displacement at the target site was reported at a
higher radiation dose (in-beam dose of 150Gy). In addition, the
corpus callosum was displaced by about 2 mm six months after
irradiation. Although the delivered dose was higher in our study
(200Gy), we did not observe similar brain damages, most likely
because of our use of 50 mm-wide MBs, a width linked to efficient
Figure 4. Immunohistological verification of the irradiation geometry. pH2AX immunolabeling performed (DNA damages) at D1 (A–F) and
D7 (F–J) in different brain regions reported on MR-images (K,L). The first row corresponds to the contralateral hemisphere (1 port), the second one the
radiation target (4 ports) and the last one to the edges of the radiation target. Scale bars represent: 200 mm (A, C, E, G, I) and 50 mm (B, D, F, H, I).
doi:10.1371/journal.pone.0009028.g004
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PLoS ONE | www.plosone.org 7 February 2010 | Volume 5 | Issue 2 | e9028Figure 5. Temporal immunohistological follow up of the radiation target. (Immuno) histological study of the contralateral hemisphere (1
port) and the radiation target (4 ports) at D1 (A–L) and D30 (L–X) after irradiation. The different rows correspond to HE staining, monocyte/
macrophage labeling (ED1, red labeling, nuclei counterstained with DAPI), cycling cells (Ki67 positive cells, red labeling, nuclei counterstained with
DAPI), brain vessels (type-IV collagen), astrocytes (GFAP) and neurons (NeuN). Scale bar represents 200 mm.
doi:10.1371/journal.pone.0009028.g005
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3 versus
40 mm
3. Indeed, as detected by MRI and immunohistochemistry,
tissue damages were confined to the region where the beams
interlaced, whatever the delays of observation. This is in
agreement with the observation that a 4000 Gy entrance dose
can be delivered to a mouse brain by a 25 mm-thin cylindrical MB
without ensuing necrosis of the tissue [8]. However, the radiation
dose tolerated by brain tissue decreased drastically with the
increase of beam width, as a 1-mm thick cylindrical beam
(entrance dose: 140 Gy) induced a macroscopic necrosis of the
mouse brain tissue [8]. The effects of MB irradiation on normal
brain are now well described in the literature [9,10,23–28] and our
previous work showed that the use of 50-mm thick MB was a safer
compromise (compared with 25 or 75 mm) between normal tissue
sparing and brain tumor control for a 200 mm spacing [20]. In the
present study, no damage was visualized by MRI in 4 control rats
irradiated by intersecting, non-interlacing arrays which created
700Gy microplanar peak doses spaced by 200 mm on-center
(valley dose of 12.5 Gy at 1 cm depth). This observation
demonstrates that the extent of MB-induced damages depends
to a large extent on preservation of spatial fractionation and also
illustrates that IAMB irradiations through several ports would be a
safe way to deliver high radiation dose to small, well-delimited
brain lesions.
Resistance of Brain Vascular Network
The radioresistance of the brain vascular network to spatially
fractionated irradiations may explain the tissue tolerance to very
high radiation doses. In this study, blood vessels were only
damaged in the radiation target. In the contralateral hemisphere,
radiogenic micro-lesions of blood vessels were rapidly repaired, in
agreement with previous studies [9,10,29]. On the contrary, the
macroscopic lesion induced in the radiation target (2 mm wide)
showed a strong decrease in vessel density and an increase in vessel
diameter. This was correlated with a significant increase in ADC
and T2w signal values and Gd-DOTA extravasation at D30 after
Figure 6. GAERS cortical irradiations and EEG follow up. A- The regions targeted in the epilepsy study were two symmetric volumes located in
the two somatosensory regions of the GAERS rat cortex. Each volume consisted of two juxtaposed cylinders (left and right figures), which geometries
were chosen to fit the somatosensory cortex that initiates absence seizures. Coordinates are relative to the bregma. B- Gafchromic film showing the
bilateral volumes irradiated using 4 interlaced arrays of MBs with an entrance dose of 200 Gy. C- Total seizure durations measured by EEG at different
times after irradiation in the control group and in the IAMB irradiated group.
doi:10.1371/journal.pone.0009028.g006
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edema formation which typically follows the radiation-induced
BBB disruption [30,31]. In case of brain tumor, such an increase
in tumor blood vessel permeability may facilitate delivery of
chemotherapeutic agents to the lesion via the circulatory system.
Indeed, due to the high intratumoral pressure and presence of a
blood tumor barrier, systemic injection of drugs remains inefficient
[32–34]. Because of the very high radiation dose delivered in the
Table 1. Human-sized head phantom Monte Carlo simulations.
Irradiation field 262m m
2 161c m
2 363c m
2
Spacing 200 400 200 400 200 400
Number of ports 4 8 4 8 4 8
PVDR at 7.5 cm 51 197.5 19.7 45.9 7.9 15.9
Arbitrary dose at the interlaced region at 7.5 cm 100 Gy
Int. enhancement factor 14% 15% 22% 23% 43% 52%
In beam required dose at 7.5 cm 88 87 82 81 70 66
Valley dose at 7.5 cm 1.73 0.45 4.16 1.76 8.7 4.1
Depth attenuation factor 0.30 0.30 0.30 0.30 0.32 0.31
Entrance peak dose required 297 293 273 270 216 210
PVDR at entrance site 71 342 38 118 22 52
Valley dose at entrance site 4.2 0.9 7.1 2.3 9.8 4.0
Calculated PVDRs, peak and valley doses at 7.5 cm depth and at the entrance site in a water phantom when delivering an arbitrary dose of 100 Gy to a 262m m
2,
161c m
2 or 363c m
2 target in the interlaced region (7.5 cm depth) with 50-mm wide MBs and for two different MB spacings. The interlacement enhancement factor
corresponds to the increase in radiation dose in the target with respect to the in-MB dose given in a single array of MBs as represented on figure 7.
doi:10.1371/journal.pone.0009028.t001
Figure 7. Human-sized head Monte Carlo dosimetry. A-PVDRs calculated at different depths for different quadratic irradiation fields. The field
size is indicated in the legend together with the spacing between MBs). B-Peak and valley depth-dose curves in water for 200 mm and 400 mm
spacing between MBs. C- Calculated dose profiles for a single MB array and for 4 interlaced arrays is shown for 161c m
2 irradiation fields. An increase
in dose of 18% is measured for the dose deposited in the interlaced region (black) compared with the dose in the MB path (single array, red). D- A
comparison of the lateral dose profile produced by the Leksell Gamma Knife (LGK) PerfexionH (blue) with the dose deposited by interlaced MB
irradiation (black) is shown for an 8 mm wide irradiation field.
doi:10.1371/journal.pone.0009028.g007
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pressure by decreasing cell density and (2) increase the amount of
drugs delivered to the tumor by locally increasing the blood vessel
permeability.
Biomedical Applications of Interlaced Microbeams
Our study strongly suggests that IAMB could be considered for
medical applications. The high tolerance of normal brain tissue to
spatially fractionated irradiation using MBs would allow very high
dose deposition in the target without impairment of radio-sensitive
surrounding brain structures situated within a single array as in the
case of Gamma knife [35,36]. However, IAMB as described in the
present work fulfils the criteria of a new type of radiosurgery with
many advantages provided by the use of the synchrotron light.
First, the highly focused, quasi-parallel synchrotron beam (,1
and ,0.1 mrad horizontal and vertical divergences respectively)
and the use of kilovoltage photons (50 to 350 keV) allows the
conservation of the shape of the MB even in the depth of soft
tissues, which is not the case when megavoltage photons are used.
As shown in our study, PVDR values do not change after crossing
about 1 cm of tissue and a very sharp lateral dose falloff was found
for IAMB compared with a LGK PerfexionH irradiation. Using
synchrotron light, only 1.5% of the radiation dose would be
deposited at 10 mm from the center of the target versus 16.2% after
LGK. The 90-10% dose falloff would be theoretically 182 fold
higher in IMAPB than in LGK (0.050 versus 9.1 mm). MRI and
histological studies clearly confirmed the high spatial selectivity of
IAMB. As shown at the edge of the radiation target, tissular and
DNA damages were confined, at a cellular scale, to the interlaced
region. This suggests that the lateral falloff and the high dose
homogeneity within the target might well improve the quality of
the outcome in clinical practice. This is a critical issue as
vulnerable or eloquent brain structures are often very close to the
target whether it is a tumor or an epileptic focus. The
submillimetric accuracy of IAMB would theoretically enable us
to target specifically subdivisions of a given brain region (e.g.,
sensorimotor or limbic subdivision of the subthalamic nucleus),
which is not feasible with a dose planning radiosurgical system. In
patient with drug-resistant focal seizures, tiny malformations or
tumors (e.g., cortical dysplasias, hypothalamic harmatomas) are
often located in functional area and not amenable to surgical
resection [37,38]. For these patients, IAMB could reduce or even
stop seizures generated by a clearly identified epileptogenic zone,
as supported by our experimental proof of concept in epileptic
rats.
Second, the high dose rate of synchrotron generated x-rays
(,16 000 Gy.s
21 at the ESRF) allows very short exposure
(typically few ms) and thus avoids the smearing out of the
radiation dose induced by the physiologic motion of the brain.
Brain motion probably constitutes the main difficulty for the
clinical transfer of IAMB. It reflects the response of the brain
parenchyma, spinal cord, and CSF changes in arterial and venous
pressure and volume during the cardiac cycle and was measured
using different imaging techniques [39–43]. The cH2AX
immunolabeled sections (Fig. 4), reveal that interlacing 4 arrays
of MBs was not hindered by brain motion in rats. However, brain
motion in rat is likely to be more limited than in the human head,
where brain motion ranges from 50 mm in the occipital, frontal
and parietal lobes to 100 mm in the hypothalamus [42], with a
maximum (184 mm) in the pons [44]. Most of these values are in
the range of the size and spacing of the MBs in IAMB. This might
alter the efficiency of the treatment by modifying the irradiation
geometry. However, brain motion has a maximum velocity of
2 mm.s
21, a few milliseconds after the R wave [45]. In addition,
every brain structure has been reported to go back with a mm
accuracy to its initial position after complete heart cycle, [42].
Therefore, heart-gated synchronized irradiations will be required
in IAMB for clinical use and the design of the ID17 beamline [16]
and a fast shutter [46] might facilitate this implementation. The
very high dose rate of the source would considerably reduce the
exposition times giving the possibility to treat several lesions in the
same patients in a limited time. This is a critical feature when
treating multiple tumor metastases in the brain [47,48].
Finally, the low energy of the x-ray photons used in IAMB might
constitute a severe disadvantage, when compared with megavoltage
photons of conventional radiotherapy. However, the 50–350 keV
white beam produced by the synchrotron preserves an adequate
PVDR; the penetration of these photons permits delivery of
important radiation doses deeply in soft tissues. In our study, the
dose falloff is only 30% of the nominal dose at 7.5 cm depth. In
addition, our irradiation geometry compensates this decrease.
Indeed,the dose contribution ofthe lateral diffusion of the secondary
electrons and photons increases the radiation dose delivery in the
radiation target compared with the individual array. This so called
‘‘Interlacement Enhancement Factor (Int.EF)’’ increases with the
size of the irradiation field and, to smaller extent with MB spacing,
up to 50% for a 363c m
2 irradiation field. Despite the fact that the
PVDRvalues andvalleydoses becomerespectively lower and higher
with the increase in field size, the Int.EF allows a significant decrease
in the entrance doses (peak and valley). Thus, for a 100 Gy
irradiation of a 27 cm
3 target located at 7.5 cm depth, valley and
peakdoses ineacharraysofMBsare lessthan10 and 300 Gy,which
are considered tolerable for normal brain tissue [9,10,25,26,28,
49–51]. By increasing the number of ports from 4 to 8, valley doses
depositedineacharrayofMBscan bereduced toabout 4 Gyorless.
The reduction of the radiation-induced edema observed after MB
exposure[9,10] would be very critical for thalamotomy [52]. Finally,
for patients with arteriovenous malformations where lesion’s size
representsaseriouslimitation,thefactthathigh-radiationdosecould
be delivered using IAMB without inducing severe edema should be
extremely helpful [53].
In conclusion, we show here that IAMB allows a discrete high
dose deposition in a given brain region and induces in confined
damages, sparing surrounding tissues. This new irradiation
method could be useful for any brain disease where extremely
precise focal tissue destruction is required. As a proof of principle,
bilateral IAMB irradiation of the somatosensory cortex, shown to
initiate spontaneous epileptic seizures in GAERS rats, significantly
reduced the occurrence and duration of electroencephalographic
spike wave discharges. Finally, the Monte-Carlo simulations
suggest that synchrotron-generated low energy x-rays are a
promising tool for high uniform dose delivery in human brains
with an extraordinarily sharp dose falloff. We suggest that most
applications of LGK radiosurgery are technically transposable by
adaptations of synchrotron x-rays for IAMB irradiations in
stereotactic conditions with optimal conformality.
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